Sudta, PichitKirk, NicholasBezos, AnnaGurlica, AnthonyMitchell, RhysWeber, ThomasWillis, AnthonyPrabpai, SamranKongsaeree, PalangponSuksamrarn, SunitKelso, MichaelParish, Christopher2015-12-100004-9425http://hdl.handle.net/1885/62321The indolin-2-one fused-ring system and the 2,4-dimethylpyrrole unit represent key structural motifs in the anticancer drug sunitinib (Sutent®) and predecessor angiogenesis inhibitors that have undergone anticancer clinical trials (e.g. semaxanib, SU5416Keywords: Angiogenesis inhibitors; Anti-angiogenic activity; Anticancer drug; Fused-ring system; In-vitro models; Intra-molecular hydrogen bonds; Structural characteristics; Structural motifs; Scaffolds; HydrocarbonsSynthesis, structural characterisation, and preliminary evaluation of non-indolin-2-one-based angiogenesis inhibitors related to sunitinib (Sutent®)201310.1071/CH132192016-02-24